China-Made Devices Could Offer Steep Competition By 2010, Exec Says
This article was originally published in The Gray Sheet
Executive Summary
Within two years Chinese brands of medical devices "will be very noticeable in the world market," says Julio A. Reategui, who directs Asia-Pacific compliance and regulatory affairs for medical imaging firm Medrad
You may also be interested in...
Mindray Doubles Patient Monitor Biz, Builds U.S. Presence With Acquisition
China-based Mindray Medical will supply components for Datascope's patient monitoring business unit after acquiring the subsidiary for $202 million in a deal announced March 11
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.